MeiraGTx Holdings PLC (MGTX)
4.16
-0.05
(-1.19%)
USD |
NASDAQ |
Jun 26, 14:09
MeiraGTx Holdings Debt to Equity Ratio: 0.5947 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.5947 |
December 31, 2023 | 0.5219 |
September 30, 2023 | 0.7819 |
June 30, 2023 | 0.5794 |
March 31, 2023 | 0.7903 |
December 31, 2022 | 0.6033 |
September 30, 2022 | 0.5775 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
Date | Value |
---|---|
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
0.7903
Maximum
Mar 2023
0.2224
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
Regeneron Pharmaceuticals Inc | 0.0735 |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.5332 |
IGC Pharma Inc | 0.0152 |
NovaBay Pharmaceuticals Inc | 6.294 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 309.24M |
Total Liabilities (Quarterly) | 187.50M |
Shareholders Equity (Quarterly) | 121.73M |
Current Ratio | 3.140 |
Net Debt Paydown Yield | -0.07% |